A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma

被引:25
|
作者
Khurana, Vinod K. [1 ,2 ]
Misri, Rachita R. [1 ,2 ]
Agarwal, Swati [1 ,2 ]
Thole, Akhilesh V. [1 ,2 ]
Kumar, Sachin [1 ,2 ]
Anand, Tanu [3 ]
机构
[1] Hindu Rao Hosp, Dept Dermatol, New Delhi, India
[2] Hindu Rao Hosp, Dept Venereol & Leprosy, New Delhi, India
[3] Hindu Rao Hosp, Dept Prevent & Social Med, New Delhi, India
关键词
Clinical trials preparation; melasma; therapeutic studies; tranexamic acid; TRANS-4-AMINOMETHYLCYCLOHEXANECARBOXYLIC ACID;
D O I
10.4103/ijdvl.IJDVL_801_16
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Melasma poses a great challenge as its treatment modalities are unsatisfactory. Treatment using tranexamic acid is a novel concept. Aim: This study aimed to compare the therapeutic efficacy and safety of oral tranexamic acid and tranexamic acid microinjections in patients with melasma. Methods: This is a prospective, randomized, open-label study with a sample size of 64, 32 in each treatment arm. Thirty-two patients were administered localized microinjections (4 mg/ml) of tranexamic acid monthly in 1 arm, while in the other arm, 32 were given oral tranexamic acid 250 mg twice a day. Patients were followed up for 3 consecutive months. Clinical photographs were taken at each visit, and a modified melasma area and severity index scoring was performed at the beginning and end of treatment. Results: Improvement in melasma area and severity index score in the oral group was 57.5% as compared to 43.5% in the intralesional group. All 32 patients in the oral group (100%) showed >50% improvement, out of which 8 showed >75% improvement. In the intralesional group, 17 (53%) patients had >50% improvement, of which 3 had >75% improvement. The remaining 15 patients in this group had <50% improvement. Thus, the oral group showed a more significant response as compared to the intralesional group. No major adverse effects were observed in both the groups. At 6-month follow-up, two patients (6.2%) in the oral group had recurrence as compared to three patients (9.4%) in the intralesional group. Limitations: A small sample size was one of the limitations in this study. The dose of tranexamic acid in microinjections and the frequency of injections could have been increased. Conclusion: Tranexamic acid provides rapid and sustained improvement in the treatment of melasma. It is easily available and affordable. Oral route is undoubtedly efficacious, but the results of microinjections, while encouraging, can probably be enhanced by either increasing the frequency of injections or increasing the concentration of the preparation.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 50 条
  • [31] Role of Oral Tranexamic Acid in Treating Patients of Melasma in A Charity Hospital of Lahore
    Sheikh, Mariam
    Rahim, Ikram Ur
    Latif, Muhammad
    Majeed, Rabail
    Awais, Muhammad
    Riaz, Sunila
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (09): : 2490 - 2492
  • [32] Efficiency of ellagic acid and arbutin in melasma:: A randomized, prospective, open-label study
    Ertam, Ilgen
    Mutlu, Basak
    Unal, Idil
    Alper, Sibel
    Kivcak, Bijen
    Ozer, Ozgen
    JOURNAL OF DERMATOLOGY, 2008, 35 (09): : 570 - 574
  • [33] A cross-sectional report on melasma among Hispanic patients: Evaluating the role of oral tranexamic acid versus oral tranexamic acid plus hydroquinone
    Arreola Jauregui, Ileana E.
    Huerta Rivera, Gabriel
    Soria Orozco, Manuel
    Meyer-Nava, Silvia
    Paniagua Santos, Juan E.
    Lopez Zaldo, Juan B.
    Meyer-Nava, Ilse
    Madrid Carrillo, Clara
    Zaldo Rolon, Iara E.
    Baeza Echeverria, Aline E.
    Vazquez-Huerta, Minerva
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (05) : 1457 - 1458
  • [34] Tranexamic acid: a promising remedy for melasma?
    Cheng, T. S.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2020, 28 (01): : 3 - 4
  • [35] A Comparative Study of Topical 3% Tranexamic Acid and 35% Glycolic Acid in Melasma and Review of Literature
    Soundarya, S.
    Devanand, N.
    Thomas, Jayakar
    Sabapathi, Vaishnavi
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (43A) : 238 - 246
  • [36] Liposomal azelaic acid 20% cream vs hydroquinone 4% cream as adjuvant to oral tranexamic acid in melasma: a comparative study
    Akl, Essam M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2008 - 2013
  • [37] Melasma Treatment With Oral Tranexamic Acid and a Novel Adjuvant Topical Therapy
    Cohen, Philip R.
    CUTIS, 2018, 102 (02): : 106 - 106
  • [38] Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma
    Aysenur Botsali
    Pelin Esme
    Hakan Erbil
    Ercan Caliskan
    Lasers in Medical Science, 2022, 37 : 2823 - 2830
  • [39] Efficacy of Oral, Topical, and Intradermal Tranexamic Acid in Patients with Melasma - A Meta-Analysis
    Panchal, Viraj S.
    Patel, Yatri S.
    Dalal, Yagnya D.
    Parikh, Amrita P.
    Dalal, Archana D.
    Rana, Devang A.
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2024, 15 (01) : 55 - 63
  • [40] A Randomized Study to Evaluate the Efficacy of Oral Tranexamic Acid, Modified Kligman's Formula, and Placebo Cream in Melasma
    Prathyoosha, S.
    Ananditha, K.
    Rao, T. Narayana
    Gopal, K. V. T.
    Raju, P. V. Krishnam
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2024, 15 (05) : 787 - 793